Baclofen

( DrugBank: Baclofen / KEGG DRUG: Baclofen )


7 diseases
IDDisease name (Link within this page)Number of trials
2Amyotrophic lateral sclerosis1
10Charcot-Marie-Tooth disease21
13Multiple sclerosis14
18Spinocerebellar degeneration1
IDDisease name (Link within this page)Number of trials
65Primary immunodeficiency1
149Hemiconvulsion hemiplegia epilepsy syndrome1
206Fragile X syndrome2

2. Amyotrophic lateral sclerosis


Clinical trials : 786Drugs : 550 - (DrugBank : 182) / Drug target genes : 170 - Drug target pathways : 232 
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries

10. Charcot-Marie-Tooth disease


Clinical trials : 45Drugs : 34 - (DrugBank : 10) / Drug target genes : 12 - Drug target pathways : 22 
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries

13. Multiple sclerosis


Clinical trials : 3,685Drugs : 1,932 - (DrugBank : 355) / Drug target genes : 263 - Drug target pathways : 237 
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries

18. Spinocerebellar degeneration


Clinical trials : 83Drugs : 83 - (DrugBank : 31) / Drug target genes : 30 - Drug target pathways : 53 
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries

65. Primary immunodeficiency


Clinical trials : 798Drugs : 585 - (DrugBank : 118) / Drug target genes : 100 - Drug target pathways : 216 
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries

149. Hemiconvulsion hemiplegia epilepsy syndrome


Clinical trials : 34Drugs : 37 - (DrugBank : 16) / Drug target genes : 17 - Drug target pathways : 30 
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries

206. Fragile X syndrome


Clinical trials : 118Drugs : 75 - (DrugBank : 30) / Drug target genes : 58 - Drug target pathways : 83 
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries